Abstract
We discuss the relevance of current trends in clinical trial conduct in light of the burgeoning need to underpin our practice with evidence, the contribution of novel imaging approaches to provide acceptable surrogate endpoints of effect and their place in the individualised medicine of the future.
Original language | English |
---|---|
Pages (from-to) | 97-100 |
Number of pages | 4 |
Journal | Journal of Medical Imaging and Radiation Oncology |
Volume | 55 |
Issue number | 1 |
DOIs | |
Publication status | Published - Feb 2011 |
Externally published | Yes |
Keywords
- cancer imaging
- personalised medicine
- radiation response
- randomised controlled trials
- surrogate endpoints